ARIA

ARIAD Pharmaceuticals, Inc. Press Releases

$8.16
*  
0.31
3.95%
Get ARIA Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading ARIA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma
7/29/2015 7:35:00 AM - Business Wire
▼-0.85 % Price Change since this news event. The Volume Ratio is 4.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results
7/22/2015 7:35:00 AM - Business Wire
▼-1.21 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial
6/12/2015 11:15:00 AM - Business Wire
▼-8.11 % Price Change since this news event. The Volume Ratio is 2.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada
6/10/2015 7:35:00 AM - Business Wire
▼-7.27 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference
6/8/2015 7:35:00 AM - Business Wire
▼-8.83 % Price Change since this news event. The Volume Ratio is 0.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD Presents Updated Clinical Data on brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer at the 2015 ASCO Meeting
6/1/2015 9:00:00 AM - Business Wire
▼-11.78 % Price Change since this news event. The Volume Ratio is 1.37.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD Announces Long-Term Safety and Efficacy Data Of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical Trial
5/31/2015 9:00:00 AM - Business Wire
▼-11.11 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress
5/22/2015 7:35:00 AM - Business Wire
▼-7.48 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ARIAD to Present at the Jefferies 2015 Global Healthcare Conference
5/21/2015 7:35:00 AM - Business Wire
▼-9.23 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting
5/14/2015 7:35:00 AM - Business Wire
▼-8.93 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day